Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

pCR Rate × Epirubicin × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 20 Triple Negative Breast Neoplasms 12 Lymphoma, Large B-Cell, Diffuse 2 Inflammatory Breast Neoplasms 2 Resectable HER2-positive Breast Cancer 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non-Muscle Invasive Bladder Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Hodgkin Disease 1 HR+/HER2- Breast Cancer 1 Epstein-Barr Virus Infections 1 Congenital Abnormalities 1 Carcinoma, Adenoid Cystic 1 CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡